BackSmith & Nephew plc Overview
Smith & Nephew plc - ADR

Smith & Nephew plc Target Price

Analysts' average 12-month price target for Smith & Nephew plc is $31.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.24

Average Target Price

$30.935.8% upside

2 analysts in the last 4 months

High: $31.85 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-11Bernstein$31.858.9% upsideOpen
2026-05-11Canaccord Genuity$302.6% upsideOpen
2026-04-24Canaccord GenuityCaitlin Cronin$329.5% upsideOpen
2025-10-14Bernstein$37.528.3% upsideOpen
2025-08-18Canaccord GenuityCaitlin Cronin$3623.1% upsideOpen
2024-11-04Canaccord GenuityKyle Rose$277.6% downsideOpen

Smith & Nephew plc (SNN) FAQ

As of the most recent data, SNN shows a target price of $31. Scroll down for historical charts and peer comparison views.

If Smith & Nephew plc moved to the average analyst target of $31, shares would be roughly 5.8% higher than $29.24. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Smith & Nephew plc's earnings trajectory.

Besides this target price page, Stockcircle has Smith & Nephew plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $31) with ownership activity and broader fundamentals.

Smith & Nephew plc's target price is $31; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.